1. Hirata Y, Ishizu H, Ouchi N, Motomura S, Abe M, Hara Y, Wakasugi H, Takahashi I, Sakano H, Tanaka M. Insulin autoimmunity in a case with spontaneous hypoglycemia. J Jpn Diabetes Soc 1970;13:312-320.
2. Hirata Y, Tominaga M, Ito JI, Noguchi A. Spontaneous hypoglycemia with insulin autoimmunity in Graves' disease. Ann Intern Med 1974;81:214-218.
[CROSSREF] [PUBMED]
3. Ichihara K, Shima K, Saito Y, Nonaka K, Tarui S. Mechanism of hypoglycemia observed in a patient with insulin autoimmune syndrome. Diabetes 1977;26:500-506.
[CROSSREF] [PUBMED]
4. Hirata Y. Methimazole and insulin autoimmune syndrome with hypoglycemia. Lancet 1983;2:1037-1038.
[CROSSREF] [PUBMED]
5. Eisenbarth GS. Immunoendocrinology: scientific and clinical aspects; Totowa: Springer Science+Business Media; 2011. Chapter 21. Insulin autoimmune syndrome (Hirata disease). p. 343-367.
6. Uchigata Y, Kuwata S, Tokunaga K, Eguchi Y, Takayama-Hasumi S, Miyamoto M, Omori Y, Juji T, Hirata Y. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet 1992;339:393-394.
[CROSSREF] [PUBMED]
7. Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol 2000;61:154-157.
[CROSSREF] [PUBMED]
8. Uchigata Y, Kuwata S, Tsushima T, Tokunaga K, Miyamoto M, Tsuchikawa K, Hirata Y, Juji T, Omori Y. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. J Clin Endocrinol Metab 1993;77:249-254.
[CROSSREF] [PUBMED]
9. Cho BY, Lee HK, Koh CS, Min HK. Spontaneous hypoglycemia and insulin autoantibodies in a patient with Graves' disease. Diabetes Res Clin Pract 1987;3:119-124.
[CROSSREF] [PUBMED]
10. Lee KS, Kim JH, Choi WH, Kim TW, Kim MH. A case report of insulin autoimmune syndrome in Graves' disease. J Korean Soc Endocrinol 1993;8:451-455.
11. Lim JK, Woo YA, Kang SJ, Yoo SS, Hong KY, Kim SH. Ensulin autoimmune syndrome in a patient with methimazole-treated Graves' disease: a case report. J Korean Soc Endocrinol 1998;13:612-616.
12. Takei M. Insulin autoantibodies produced by methimazole treatment in patients with Graves' disease. J Tokyo Women Med Coll 1980;50:54-68.
13. Uchigata Y, Eguchi Y, Takayama-Hasumi S, Omori Y. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract 1994;22:89-94.
[CROSSREF] [PUBMED]
14. Takeuchi Y, Miyamoto T, Kakizawa T, Shigematsu S, Hashizume K. Insulin autoimmune syndrome possibly caused by alpha lipoic acid. Intern Med 2007;46:237-239.
[CROSSREF] [PUBMED]
15. Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S, Obata F, Tadokoro K, Hirata Y, Omori Y, et al. Recognition of human insulin in the context of HLA-DRB1* 0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol 1993;151:5770-5776.
[CROSSREF] [PUBMED] [PDF]
16. Roh EY, Kim HS, Kim SM, Lim YM, Han BY, Park MH. HLA-A, -B, -DR allele frequencies and haplotypic associations in Koreans defined by generic-level DNA typing. Korean J Lab Med 2003;23:420-430.
17. Park MH, Park YJ, Song EY, Park H, Kim TY, Park DJ, Park KS, Cho BY. Association of HLA-DR and -DQ genes with Graves disease in Koreans. Hum Immunol 2005;66:741-747.
[CROSSREF] [PUBMED]
18. Eguchi Y, Uchigata Y, Yao K, Yokoyama H, Hirata Y, Omori Y. Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata's disease). Autoimmunity 1994;19:279-284.
[CROSSREF] [PUBMED]
19. Yaturu S, DePrisco C, Lurie A. Severe autoimmune hypoglycemia with insulin antibodies necessitating plasmapheresis. Endocr Pract 2004;10:49-54.
[CROSSREF] [PUBMED] [PDF]
20. Yu L, Herold K, Krause-Steinrauf H, McGee PL, Bundy B, Pugliese A, Krischer J, Eisenbarth GS. Type 1 Diabetes TrialNet Anti-CD20 Study Group. Rituximab selectively suppresses specific islet antibodies. Diabetes 2011;60:2560-2565.
[CROSSREF] [PUBMED] [PMC]